Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
Viatris Inc
A global healthcare company that makes and sells generic medicines, complex drugs, and iconic brand-name products like Lipitor® and Lyrica®, reaching hundreds of millions of patients across more than a hundred countries. Viatris was created in 2020 when the drugmaker Mylan merged with Upjohn, the off-patent medicines arm of Pfizer, uniting two long pharmaceutical histories. It has since streamlined by selling off its women's health, over-the-counter, and active-ingredient businesses.
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits
8.01 Other Events · 9.01 Financial Statements and Exhibits
5.07 Submission of Matters to a Vote of Security Holders
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 2.05 Costs Associated with Exit or Disposal Activities · 8.01 Other Events · 9.01 Financial Statements and Exhibits